Given that the activation signature of Treg is dependent on TCR signals (Figure 6), these results suggest that FOXP3 expression occurs predominantly in the activated T cells that have recognized the tumor antigens and received TCR signals, as a negative feedback mechanism to suppress the effector response against the tumor antigens (7). This evidence concerns the gene FOXP3 and neoplasm.